Navigation Links
Longs Reports Preliminary March Retail Drug Store Sales
Date:4/10/2008

WALNUT CREEK, Calif., April 10 /PRNewswire-FirstCall/ -- Longs Drug Stores Corporation (NYSE: LDG) today reported preliminary total retail drug store sales for the five-week and nine-week periods ended April 3, 2008.

Periods ended April 3, 2008

Month Quarter to Date

(Dollars in millions) (5 weeks) (9 weeks)

Total retail drug store sales $474 $853

Increase from comparable prior year

period 4.7% 4.0%

Same-store sales increase:

Pharmacy 0.1% 1.0%

Front-end 5.7% 3.2%

Total 2.8% 2.1%

Longs estimated that preliminary March front-end same-store sales were favorably impacted by approximately 350 to 400 basis points as a result of the three-week shift in Easter holiday sales. Easter occurred on March 23 this year versus April 18 last year.

Longs estimated that preliminary March pharmacy same-store sales were unfavorably impacted by approximately 525 to 575 basis points as a result of recent generic introductions being substituted for higher-priced brand name drugs. In addition, the switch of the prescription allergy medicine Zyrtec to over-the-counter status and a mild conclusion to the cold and flu season versus last year had an unfavorable impact of approximately 125 to 150 basis points on pharmacy same-store sales.

About the Company

Headquartered in Walnut Creek, California, Longs Drug Stores Corporation (NYSE: LDG) is one of the most recognized retail drug store chains on the West Coast and in Hawaii. The Company operates 512 retail pharmacies and offers a wide assortment of merchandise focusing on health, wellness, beauty and convenience. Longs also provides pharmacy benefit management services and Medicare beneficiary prescription drug plans through its wholly-owned subsidiary, RxAmerica, LLC. Additional information about Longs and its services is available at http://www.longs.com and more information about RxAmerica is available at http://www.rxamerica.com.

Contact: 925-979-3979


'/>"/>
SOURCE Longs Drug Stores Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Longs Drugs Announces Immunization Program for the 2007/2008 Flu Season
2. New chemotherapy regimen prolongs survival in difficult-to-treat childhood brainstem gliomas
3. Longs Drugs Plans to Become the First Retailer in Hawaii With Walk-in Medical Clinics
4. Thalidomide Added to Standard Therapy Prolongs Overall Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75
5. Treating oft ignored non-cancer health issues after cancer diagnosis prolongs survival
6. Longs Drug Stores Corporation Declares Cash Dividend on Common Shares
7. Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008
8. Longs Reports Preliminary February Retail Drug Store Sales
9. Longs Drug Stores Announces Todd Vasos Executive Vice President and Chief Operating Officer
10. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
11. Haemacure Reports Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Z-Medica, LLC, ... of Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to ... developed in association with efforts by the American College of Surgeons, U.S. Department ...
(Date:3/28/2017)... ... 28, 2017 , ... The Radiology Business Management Association (RBMA) is ... its new executive director. Mr. Still was selected through a careful months-long search by ... he is known to our members, has been a part of building the RBMA ...
(Date:3/28/2017)... ... 28, 2017 , ... Qualidigm , the mission-driven national ... a new, more expansive office space in order to accommodate its growing number ... office building in Wethersfield, Conn. located at 936 Silas Deane Highway and immediately ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... corrosive ions found in power plant water and steam. , Chlorides and sulfates ... and boilers, leading to extensive maintenance and unplanned shutdowns. Monitoring these ions at ...
(Date:3/28/2017)... ... March 28, 2017 , ... Columbus OH. Dr. Justin ... one of few medical professionals in the country to sit on the 2017 National ... Aesthetics, in just 2 years Dr. Harper helped propel the clinic from a small ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... Mass. , March 28, 2017 ... company developing innovative therapeutics that address significant unmet ... a patent from the Japan Patent Office (JPO) ... connective tissue growth factor (CTGF) for the treatment ... limited to skin fibrosis and proliferative retinopathy (Japanese ...
(Date:3/28/2017)... England , March 28, 2017 ... collaborative research with Cambridge ... Therapeutics Consortium   The Milner Therapeutics Institute today ... Consortium. Elysium Health has committed significant investment for collaborative projects ... the next four years. This is the first major research ...
(Date:3/27/2017)... March 27, 2017 Therapix ... pharmaceutical company specializing in the development of cannabinoid-based drugs, ... in the United States ... representing 40 ordinary shares of the Company, at ... Therapix has granted the underwriters a 45-day over-allotment ...
Breaking Medicine Technology: